Identification and treatment of T2-low asthma in the era of biologics
Currently, and based on the development of relevant biologic therapies, T2-high is the most well-defined endotype of asthma. Although much progress has been made in elucidating T2-high inflammation pathways, no specific clinically applicable biomarkers for T2-low asthma have been identified. The the...
Uložené v:
| Vydané v: | ERJ open research Ročník 7; číslo 2; s. 309 |
|---|---|
| Hlavní autori: | , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
England
European Respiratory Society
01.04.2021
|
| Predmet: | |
| ISSN: | 2312-0541, 2312-0541 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
Buďte prvý, kto okomentuje tento záznam!